Septerna (SEPN) Accumulated Depreciation (2023 - 2026)

Septerna's quarterly Accumulated Depreciation came in at $4.8 million in Q1 2026, up 43.51% year-on-year from $3.3 million in Q1 2025, and up 9.67% quarter-over-quarter from $4.4 million in Q4 2025.

Septerna has reported Accumulated Depreciation for 4 years, with the latest figure at $4.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Accumulated Depreciation rose 43.51% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $4.8 million (up 43.51% YoY), and the FY2025 full-year result was $4.4 million, up 48.58% from the prior year.
  • Accumulated Depreciation for Q1 2026 stood at $4.8 million, up from $4.4 million in the prior quarter.
  • The five-year high for Accumulated Depreciation was $4.8 million in Q1 2026, with the low at $1.6 million in Q4 2023.
  • Average Accumulated Depreciation over 4 years is $3.4 million, with a median of $3.5 million recorded in 2025.
  • Year-over-year, Accumulated Depreciation jumped 80.58% in 2024 and soared 43.51% in 2026.
  • Tracing SEPN's Accumulated Depreciation over 4 years: stood at $1.6 million in 2023, then jumped by 80.58% to $2.9 million in 2024, then soared by 48.58% to $4.4 million in 2025, then gained by 9.67% to $4.8 million in 2026.
  • The last three Accumulated Depreciation figures came in at $4.8 million (Q1 2026), $4.4 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Septerna 1.34 Bn 1.34 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.77 Mn
Dec 31, 2025 4.35 Mn
Sep 30, 2025 4.06 Mn
Jun 30, 2025 3.72 Mn
Mar 31, 2025 3.33 Mn
Dec 31, 2024 2.93 Mn
Sep 30, 2024 2.54 Mn
Dec 31, 2023 1.62 Mn